How Bevacizumab Monotherapy Can Help Patients with ROP

Did you miss the July 5th issues of the Ophthalmology Times eReport? In this e-newsletter we released information on Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity, gender difference in presbyopia assistance, a scholarship for the “most beautiful eyes” and more. Check out the articles in this issue below.

Bevacizumab monotherapy shows potential for some patients with ROP

Bevacizumab (Avastin, Genentech) monotherapy for zone I retinopathy of prematurity (ROP) might have potential for treating pre-term infants who are in phase II of the pathogenesis of ROP. Read more

Gender differences may factor into presbyopia assistance

Ophthalmologists should consider gender differences in arm length and reading distance preferences when prescribing reading glasses or bifocal lenses, according to a recent study published in Investigative Ophthalmology & Visual Science. Such factors mean that women tend to desire assistance with presbyopia symptoms earlier than men do. Read more

George Bartley to become Ophthalmology editor in January

George B. Bartley, MD, will succeed Andrew P. Schachat, MD, as editor-in-chief of Ophthalmology, the American Academy of Ophthalmology’s (AAO’s) flagship journal, in January. Dr. Schachat has served in this capacity since 2003. Read more

Scholarship to be awarded for ‘most beautiful eyes’

A $10,000 educational scholarship is up for grabs in Prevent Blindness America’s (PBA’s) 2012 Most Beautiful Eyes Contest. Read more

Vitrectomy system gains 510(k) clearance

Synergetics USA Inc. has received 510(k) marketing clearance from the FDA for its proprietary vitrectomy system (VersaVIT). Read more

Acucela receives ‘Emerging Leader’ award

Acucela Inc. has been named as a recipient of the 2012 Emerging Leaders award from the Japan-U.S. Innovation Awards. Read more

NicOx, RPS sign worldwide licensing agreement

NicOx S.A. and Rapid Pathogen Screening Inc (RPS) have entered into a licensing agreement that gives NicOx access to RPS’s point-of-care ocular diagnostic tests. Read more

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s